Cargando…
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
To address the COVID-19 pandemic, there has been an unprecedented global effort to advance potent neutralizing mAbs against SARS-CoV-2 as therapeutics. However, historical efforts to advance antiviral monoclonal antibodies (mAbs) for the treatment of other respiratory infections have been met with c...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833882/ https://www.ncbi.nlm.nih.gov/pubmed/33309815 http://dx.doi.org/10.1016/j.addr.2020.12.004 |